Human Complement C5 Deficient EDTA Plasma

• Description:

  Human Complement C5 Deficient EDTA Plasma_x000D_ Catalog number: B2015119_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 1 mL_x000D_ Molecular Weight or Concentration: N/A_x000D_ Supplied as: Plasma_x000D_ Applications: molecular tool for various biochemical applications_x000D_ Storage: N/A_x000D_ Keywords: Complement Component 5, Complement Component V, C5, CV, C5a, C5b, Complement C5_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Shattil SJ, Cines DB, Schreiber AD. Increased fluidity of human platelet membranes during complement-mediated immune platelet injury J Clin Invest. 1978 Mar;61(3):582-9._x000D_ 2: Zilow G, Zilow EP, Burger R, Linderkamp O. Complement activation in newborn infants with early onset infection Pediatr Res. 1993 Aug;34(2):199-203._x000D_ 3: Larcher VF, Wyke RJ, Vergani D, Mowat AP, Williams R. Yeast opsonisation and complement in children with liver disease. Analysis of 69 cases Pediatr Res. 1983 Apr;17(4):296-300._x000D_ 4: Wagner JL, Hugli TE. Radioimmunoassay for anaphylatoxins: a sensitive method for determining complement activation products in biological fluids Anal Biochem. 1984 Jan;136(1):75-88._x000D_ 5: Hardersen R, Enebakk T, Christiansen D, Bergseth G, Brekke OL, Mollnes TE, Lappegård KT, Hovland A. Granulocyte and monocyte CD11b expression during plasma separation is dependent on complement factor 5 (C5) - an ex vivo study with blood from a C5-deficient individual APMIS. 2018 Apr;126(4):342-352._x000D_ 6: Servais A, Noël LH, Frémeaux-Bacchi V, Lesavre P. C3 glomerulopathy Contrib Nephrol. 2013;181:185-93._x000D_ 7: Sullivan BL, Takefman DM, Spear GT. Complement can neutralize HIV-1 plasma virus by a C5-independent mechanism Virology. 1998 Sep 1;248(2):173-81._x000D_ 8: Nilsson PH, Johnson C, Quach QH, Macpherson A, Durrant O, Pischke SE, Fure H, Landsem A, Bergseth G, Schjalm C, Haugaard-Kedström LM, Huber-Lang M, van den Elsen J, Brekke OL, Mollnes TE. A Conformational Change of Complement C5 Is Required for Thrombin-Mediated Cleavage, Revealed by a Novel Ex Vivo Human Whole Blood Model Preserving Full Thrombin Activity J Immunol. 2021 Sep 15;207(6):1641-1651._x000D_ 9: Newsom-Davis J. Lambert-Eaton myasthenic syndrome Springer Semin Immunopathol. 1985;8(1-2):129-40._x000D_ 10: Whaley K, Schwaeble W. Complement and complement deficiencies Semin Liver Dis. 1997;17(4):297-310. _x000D_ _x000D_ Products Related to Human Complement C5 Deficient EDTA Plasma can be found at Biofluids

• Short Description:

  Catalog Number: B2015119 (1 mL)_x000D_ Human Complement C5 Deficient EDTA Plasma is a high quality Human Complement C5 Deficient EDTA Plasma. This product has been used as molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request._x000D_ _x000D_

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height :

  0.5